Adductor Canal Block Combined With Local Infiltration Analgesia vs Local Infiltration Analgesia Alone for Postoperative Pain in Total Knee Arthroplasty
ADB_01
Comparison of the Effect of Adductor Canal Block Combined With Local Infiltration Analgesia Versus Local Infiltration Analgesia Alone on Postoperative Pain Scores in Total Knee Arthroplasty
1 other identifier
interventional
61
1 country
1
Brief Summary
Total knee arthroplasty (TKA) is commonly associated with significant postoperative pain, which may impair early mobilization and functional recovery. Multimodal analgesia techniques are widely used to improve postoperative pain control while minimizing opioid consumption. Local infiltration analgesia (LIA) is a commonly used method; however, its effectiveness may be limited when used alone. The adductor canal block (ACB) provides effective analgesia while preserving quadriceps muscle strength. This prospective randomized controlled study aims to compare the effectiveness of adductor canal block combined with local infiltration analgesia versus local infiltration analgesia alone on postoperative pain scores in patients undergoing total knee arthroplasty. The primary outcome is postoperative pain assessed using the NRS at multiple time points within the first 48 hours. Secondary outcomes include opioid consumption, functional recovery parameters and hemodynamic parameters. The results of this study are expected to contribute to optimizing postoperative analgesia strategies in total knee arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2025
CompletedFirst Submitted
Initial submission to the registry
March 24, 2026
CompletedFirst Posted
Study publicly available on registry
April 8, 2026
CompletedApril 8, 2026
March 1, 2026
6 months
March 24, 2026
April 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain at rest (Numerating Rating Scale, NRS)
Postoperative pain was assessed using the NRS at rest at predefined time points. Postoperative pain was assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Pain scores were recorded at rest at predefined time points.
2,6,12,24,48
Secondary Outcomes (4)
Opioid Consumption
0-48 hours postoperatively
Knee flexion range of motion (degrees) measured with a goniometer
24 and 48 hours postoperatively
Heart rate (beats per minute)
Baseline (preoperative) and every 15 minutes from induction of anesthesia to extubation
Mean arterial pressure (mmHg)
Baseline (before induction of anesthesia) and every 15 minutes from induction of anesthesia to extubation
Study Arms (2)
ACB+LIA
EXPERIMENTALPatients in this group received an adductor canal block combined with local infiltration analgesia for postoperative pain management following total knee arthroplasty.
LIA
ACTIVE COMPARATORPatients in this group received local infiltration analgesia alone for postoperative pain management following total knee arthroplasty.
Interventions
Local infiltration analgesia was administered intraoperatively using local anesthetic agents around the surgical site.
Ultrasound-guided adductor canal block was performed using local anesthetic to provide postoperative analgesia.
Eligibility Criteria
You may qualify if:
- Patients aged 18 years and older
- Patients scheduled for elective total knee arthroplasty
- American Society of Anesthesiologists (ASA) physical status I-III
- Patients who provided written informed consent
You may not qualify if:
- Known allergy to local anesthetics
- Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
- Infection at the injection site
- Severe hepatic or renal dysfunction
- Neurological disorders affecting lower extremities
- Cognitive impairment preventing pain assessment
- Refusal to participate
- Body mass index (BMI) greater than 30 kg/m²
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara University Faculty of Medicine, Ibni Sina Hospital
Ankara, Ankara, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Physician
Study Record Dates
First Submitted
March 24, 2026
First Posted
April 8, 2026
Study Start
May 31, 2025
Primary Completion
November 15, 2025
Study Completion
November 15, 2025
Last Updated
April 8, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share